SNN vs. GEHC, PHG, ZBH, SOLV, PEN, STVN, GKOS, NARI, IRTC, and TMDX
Should you be buying Smith & Nephew SNATS stock or one of its competitors? The main competitors of Smith & Nephew SNATS include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry.
Smith & Nephew SNATS vs. Its Competitors
GE HealthCare Technologies (NASDAQ:GEHC) and Smith & Nephew SNATS (NYSE:SNN) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, analyst recommendations and institutional ownership.
GE HealthCare Technologies has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Comparatively, Smith & Nephew SNATS has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500.
GE HealthCare Technologies presently has a consensus price target of $88.27, suggesting a potential upside of 15.97%. Smith & Nephew SNATS has a consensus price target of $28.00, suggesting a potential downside of 7.16%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, equities analysts clearly believe GE HealthCare Technologies is more favorable than Smith & Nephew SNATS.
GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew SNATS pays an annual dividend of $0.89 per share and has a dividend yield of 3.0%. GE HealthCare Technologies pays out 2.9% of its earnings in the form of a dividend. Smith & Nephew SNATS pays out 41.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has raised its dividend for 1 consecutive years.
GE HealthCare Technologies has a net margin of 11.02% compared to Smith & Nephew SNATS's net margin of 0.00%. GE HealthCare Technologies' return on equity of 24.95% beat Smith & Nephew SNATS's return on equity.
82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 0.3% of GE HealthCare Technologies shares are owned by company insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, GE HealthCare Technologies had 24 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 25 mentions for GE HealthCare Technologies and 1 mentions for Smith & Nephew SNATS. GE HealthCare Technologies' average media sentiment score of 1.28 beat Smith & Nephew SNATS's score of 1.22 indicating that GE HealthCare Technologies is being referred to more favorably in the media.
GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew SNATS. Smith & Nephew SNATS is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
GE HealthCare Technologies beats Smith & Nephew SNATS on 17 of the 20 factors compared between the two stocks.
Get Smith & Nephew SNATS News Delivered to You Automatically
Sign up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SNN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Smith & Nephew SNATS Competitors List
Related Companies and Tools
This page (NYSE:SNN) was last updated on 7/2/2025 by MarketBeat.com Staff